New Zealand King Salmon Warns of Higher Mortality, Lower Growth Impacting 2026 Profits, Shares Down 9%

MT Newswires Live
03-17

New Zealand King Salmon Investments (ASX:NZK, NZE: NZK) said it's experiencing higher than expected sea farm mortality and lower than anticipated growth rates which will impact harvest volumes for fiscal year 2026, according to a Monday Australian and New Zealand bourse filing.

This situation will not impact the current fiscal year guidance of NZ$26 million to NZ$30 million on pro-forma operating earnings before interest, taxes, depreciation, and amortization basis, as the elevated mortality has occurred post after Jan. 31 but will impact the company's harvest and profitability, the filing added.

The company said the mortality levels are significantly lower than the mortality that occurred at the end of the fiscal year 2022 and the beginning of the fiscal year 2023.

Initial estimates for the fiscal year 2026 harvest are now between 5,900 and 6,300 metric tonnes gross and gutted with a pro-forma operating EBITDA range likely to be NZ$15m to NZ$24 million.

The company's shares dropped nearly 9% in recent Monday trade.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10